Moderna, Inc. 8-K Report Overview: Key Insights & Filing Details

Based on the provided section of the financial report, here are the key insights and information extracted:

1. Entity Information:

• Company Name: Moderna, Inc.
• CIK (Central Index Key): 0001682852
• State of Incorporation: Delaware (DE)
• SEC File Number: 001-38753
• EIN (Employer Identification Number): 81-3467528

2. Address:

• Location: 325 Binney Street, Cambridge, MA 02142
• Contact Number: 617-714-6500

3. Security Information:

• Type of Security: Common stock
• Par Value: $0.0001 per share
• Ticker Symbol: MRNA (traded on NASDAQ)

4. Filing Information:

• Filing Type: 8-K
• Filing Date: November 6, 2025

5. Period of Reporting:

• Start Date: November 6, 2025
• End Date: November 6, 2025

6. Miscellaneous:

• The report is formatted in XBRL (eXtensible Business Reporting Language), which is commonly used for financial reporting to facilitate data sharing and analysis.

This summary captures the essential details regarding Moderna, Inc. as of the specified filing date.